In-Vitro Fertilization Market
In-Vitro Fertilization (IVF) Market Size, Share & Trends Analysis By Procedure Type (Frozen Donor, Frozen Non-Donor, Fresh Donor, Fresh Non-Donor, Embryo Banking), By Product (Reagents, Equipment, and Software), By End-User (Hospitals and Research Laboratories, Fertility Clinics and Surgical Centers, and Others), Forecast Period (2026-2035)
Industry Overview
In-vitro fertilization (IVF) market was valued at $1,050.0 Million in 2025 and is projected to reach $2,308.9 Million by 2035, growing at a CAGR of 8.3% during the forecast Period (2026-2035). The market growth is driven by rising infertility rates (due to delayed childbearing, lifestyle factors, and chronic diseases) and tech advancements (ICSI, embryo freezing), with Europe and North America leading, while Asia-Pacific grows fastest its key factors include increased acceptance, medical tourism, and supportive policies, countered by high costs.
Market Dynamics
Rising Infertility Rates
A primary driver of the global IVF market is the increasing prevalence of infertility worldwide. Factors such as delayed parenthood, unhealthy lifestyles, environmental pollutants, and medical conditions like polycystic ovary syndrome (PCOS) and endometriosis contribute to rising infertility cases. Globally, approximately 15% of couples of reproductive age face fertility issues, creating a substantial and growing demand for assisted reproductive technologies such as IVF. The surge in infertility rates is especially pronounced in developed regions due to delayed family planning, while emerging economies are witnessing growth due to improved healthcare access, fueling market expansion.
Technological Advancements in IVF Procedures
Continuous innovation in IVF technology significantly drives market growth. Improvements such as advanced embryo culture systems, preimplantation genetic testing (PGT), vitrification (rapid freezing) techniques, and AI-assisted embryo selection have enhanced treatment success rates and clinical efficiency. These technological developments increase patient confidence in IVF procedures and broaden adoption. Additionally, integration of robotic and automated laboratory systems reduces human error and improves overall outcomes, making IVF more appealing and accessible to a larger patient base.
Increasing Awareness and Accessibility
Growing public awareness of infertility treatments and supportive healthcare initiatives are major contributors to market growth. Educational campaigns, reduced social stigma, and expanding coverage by insurance providers make IVF more accessible to couples and individuals seeking reproductive assistance. Furthermore, the proliferation of fertility clinics, particularly in Asia-Pacific and Latin America, alongside favorable regulatory frameworks, has increased availability and affordability of IVF services. Greater accessibility and acceptance of assisted reproductive technologies are helping to expand the market across both developed and emerging regions.
Market Segmentation
- Based on the procedure type, the market is segmented into frozen donor, frozen non-donor, fresh donor, fresh non-donor, and embryo banking.
- Based on the product, the market is segmented into reagents, equipment, and software.
- Based on the end-user, the market is segmented into hospitals and research laboratories, fertility clinics and surgical centers, and others.
Frozen Non-Donor Segment to Grow at a Considerable Market Share
The frozen non-donor procedure type is expected to lead the market, driven by its increasing preference among patients and clinics due to higher success rates, reduced risk of ovarian hyperstimulation, and flexibility in treatment scheduling. This segment benefits from advancements in cryopreservation technologies, which enable the safe storage and utilization of embryos, ensuring better outcomes and allowing for repeated use if necessary. The rising awareness about fertility preservation and growing adoption of assisted reproductive technologies (ART) in developed regions such as North America and Europe further bolsters the dominance of the Frozen Non-Donor segment, making it the largest contributor to the overall IVF market growth.
Fertility Clinics and Surgical Centers: A Key Segment in Market Growth
The fertility clinics and surgical centers segment under the end-user category is expected to be the key growth driver over the forecast period. This segment’s prominence is primarily attributed to the increasing number of couples seeking specialized fertility treatments and the rising prevalence of infertility worldwide. Fertility clinics and surgical centers offer comprehensive IVF services, including advanced procedures such as intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and egg or sperm freezing, which are driving higher patient volumes.
Moreover, these centers are increasingly adopting state-of-the-art equipment and automation technologies, which enhance success rates and reduce procedural times, thereby attracting more patients. The rising awareness and acceptance of assisted reproductive technologies (ART), coupled with expanding insurance coverage and government initiatives supporting fertility treatments in key regions, are further contributing to the growth of this segment. Additionally, the trend of medical tourism for fertility treatments in countries with advanced healthcare infrastructure is strengthening the market position of fertility clinics and surgical centers. Overall, this segment’s focus on patient-centric care, technological advancements, and accessibility is positioning it as the leading contributor to the growth of the global IVF market.
Regional Outlook
The global in-vitro fertilization (IVF) market is further divided by geography, including North America (the US and Canada), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), and the Rest of the World (the Middle East & Africa, and Latin America).
North America Region to Hold a Substantial Growth Rate
In North America, the US dominates the global in-vitro fertilization (IVF) market,, holding a major share due to its advanced healthcare infrastructure, high adoption of assisted reproductive technologies (ART), and strong presence of key market players. The country has witnessed a significant rise in infertility cases, driven by factors such as delayed parenthood, lifestyle changes, obesity, and other reproductive health issues, which have led to increased demand for IVF procedures. Moreover, the U.S. market benefits from well-established fertility clinics and surgical centers that offer a wide range of advanced services, including egg and sperm donation, preimplantation genetic testing (PGT), and cryopreservation techniques, contributing to higher success rates and patient satisfaction. Supportive government policies, insurance coverage for fertility treatments in certain states, and growing awareness of infertility solutions further fuel market growth. Additionally, the US is a preferred destination for medical tourism in reproductive healthcare due to its cutting-edge technologies and experienced specialists. The strong focus on research and development, coupled with continuous technological advancements in IVF equipment, reagents, and software, reinforces the country’s leading position. Overall, the US combination of healthcare expertise, innovation, and rising demand for fertility services makes it the dominant market for IVF globally.
Market Players Outlook
The major companies operating in the global in-vitro fertilization (IVF) market include CooperSurgical Inc., Cook Medical Inc., Merck KGaA, Thermo Fisher Scientific Inc., Vitrolife AB, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisitions to expand their businesses and develop innovative products to maintain their market positioning.
Recent Development
- In February 2025, NewGen IVF acquired MicroSort, a sperm-sorting technology that enhances assisted reproductive services. This acquisition strengthens NewGen IVF's position in the global fertility market and expands patient options. MicroSort separates sperm based on X and Y chromosomes, allowing for family balancing and prevention of X-linked genetic disorders. It is commercially available in several countries, and its integration into NewGen IVF's services enables tailored reproductive options, providing patients more control over their treatment. This strategic investment further reinforces NewGen IVF's financial strength and quality of care.
The Report Covers
- Market value data analysis for 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global in-vitro fertilization (IVF) market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global In-Vitro Fertilization (IVF) Market Sales Analysis – Procedure Type | Product | End-User ($ Million)
- In-Vitro Fertilization (IVF) Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key In-Vitro Fertilization (IVF) Market Trends
- Market Recommendations
- Porter's Five Forces Analysis for the In-Vitro Fertilization (IVF) Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global In-Vitro Fertilization (IVF) Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global In-Vitro Fertilization (IVF) Market: Impact Analysis
- Market Opportunities
- Opportunities For Global In-Vitro Fertilization (IVF) Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – In-Vitro Fertilization (IVF) Market Revenue and Share by Manufacturers
- In-Vitro Fertilization (IVF) Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- CooperSurgical Inc
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Cook Medical Inc
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Merck KGaA
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Thermo Fisher Scientific Inc
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Vitrolife AB
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- CooperSurgical Inc
- Key Company Analysis
- Global In-Vitro Fertilization (IVF) Market Sales Analysis by Procedure Type ($ Million)
- Frozen Donor
- Frozen Non-Donor
- Fresh Donor
- Fresh Non-Donor
- Global In-Vitro Fertilization (IVF) Market Sales Analysis by Product ($ Million)
- Reagents
- Equipment
- Software
- Global In-Vitro Fertilization (IVF) Market Sales Analysis by End-User ($ Million)
- Hospitals and Research Laboratories
- Fertility Clinics and Surgical Centers
- Others
- Regional Analysis
- North American In-Vitro Fertilization (IVF) Market Sales Analysis – Procedure Type | Product | End-User | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European In-Vitro Fertilization (IVF) Market Sales Analysis – Procedure Type | Product | End-User | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific In-Vitro Fertilization (IVF) Market Sales Analysis – Procedure Type | Product | End-User | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World In-Vitro Fertilization (IVF) Market Sales Analysis – Procedure Type | Product | End-User | Country ($ Million)
- Macroeconomic Factors for the Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Boston IVF
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Carl Zeiss AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cook Medical Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- CooperSurgical Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Corning Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Eppendorf
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Esco Micro Pte. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Ferring Pharmaceuticals
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- FUJIFILM Irvine Scientific
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Genea Biomedx Pty Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hamilton Thorne Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- IVI RMA Global
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Kitazato Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Merck KGaA
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Nikon Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Roche
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Rocket Medical plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Thermo Fisher Scientific Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Virtus Health Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Vitrolife AB
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Boston IVF
1. Global In-Vitro Fertilization (IVF) Market Research and Analysis by Procedure Type, 2025–2035 ($ Million)
2. Global Frozen Donor In-Vitro Fertilization (IVF) Market Research And Analysis By Region, 2025–2035 ($ Million)
3. Global Frozen Non-Donor In-Vitro Fertilization (IVF) Market Research And Analysis By Region, 2025–2035 ($ Million)
4. Global Fresh Donor In-Vitro Fertilization (IVF) Market Research And Analysis By Region, 2025–2035 ($ Million)
5. Global Fresh Non-Donor In-Vitro Fertilization (IVF) Market Research And Analysis By Region, 2025–2035 ($ Million)
6. Global In-Vitro Fertilization (IVF) Market Research and Analysis by Product, 2025–2035 ($ Million)
7. Global In-Vitro Fertilization (IVF) Reagents Market Research And Analysis By Region, 2025–2035 ($ Million)
8. Global In-Vitro Fertilization (IVF) Equipment Market Research And Analysis By Region, 2025–2035 ($ Million)
9. Global In-Vitro Fertilization (IVF) Software Market Research And Analysis By Region, 2025–2035 ($ Million)
10. Global In-Vitro Fertilization (IVF) Market Research and Analysis by End-User, 2025–2035 ($ Million)
11. Global In-Vitro Fertilization (IVF) For Hospitals and Research Laboratories Market Research And Analysis By Region, 2025–2035 ($ Million)
12. Global In-Vitro Fertilization (IVF) For Fertility Clinics and Surgical Centers Market Research And Analysis By Region, 2025–2035 ($ Million)
13. Global In-Vitro Fertilization (IVF) For Other End User Market Research And Analysis By Region, 2025–2035 ($ Million)
14. Global In-Vitro Fertilization (IVF) Market Research and Analysis by Region, 2025–2035 ($ Million)
15. North American In-Vitro Fertilization (IVF) Market Research and Analysis by Procedure Type, 2025–2035 ($ Million)
16. North American In-Vitro Fertilization (IVF) Market Research and Analysis by Product, 2025–2035 ($ Million)
17. North American In-Vitro Fertilization (IVF) Market Research and Analysis by End-User, 2025–2035 ($ Million)
18. European In-Vitro Fertilization (IVF) Market Research and Analysis by Procedure Type, 2025–2035 ($ Million)
19. European In-Vitro Fertilization (IVF) Market Research and Analysis by Product, 2025–2035 ($ Million)
20. European In-Vitro Fertilization (IVF) Market Research and Analysis by End-User, 2025–2035 ($ Million)
21. Asia-Pacific In-Vitro Fertilization (IVF) Market Research and Analysis by Procedure Type, 2025–2035 ($ Million)
22. Asia-Pacific In-Vitro Fertilization (IVF) Market Research and Analysis by Product, 2025–2035 ($ Million)
23. Asia-Pacific In-Vitro Fertilization (IVF) Market Research and Analysis by End-User, 2025–2035 ($ Million)
24. Rest of the World In-Vitro Fertilization (IVF) Market Research and Analysis by Region, 2025–2035 ($ Million)
25. Rest of the World In-Vitro Fertilization (IVF) Market Research and Analysis by Procedure Type, 2025–2035 ($ Million)
26. Rest of the World In-Vitro Fertilization (IVF) Market Research and Analysis by Product, 2025–2035 ($ Million)
27. Rest of the World In-Vitro Fertilization (IVF) Market Research and Analysis by End-User, 2025–2035 ($ Million)
1. Global In-Vitro Fertilization (IVF) Market Share by Procedure Type, 2025 Vs 2035 (%)
2. Global Frozen Donor In-Vitro Fertilization (IVF) Market Share by Region, 2025 Vs 2035 (%)
3. Global Frozen Non-Donor In-Vitro Fertilization (IVF) Market Share by Region, 2025 Vs 2035 (%)
4. Global Fresh Donor In-Vitro Fertilization (IVF) Market Share by Region, 2025 Vs 2035 (%)
5. Global Fresh Non-Donor In-Vitro Fertilization (IVF) Market Share by Region, 2025 Vs 2035 (%)
6. Global In-Vitro Fertilization (IVF) Market Share by Product, 2025 Vs 2035 (%)
7. Global In-Vitro Fertilization (IVF) Reagents Market Share by Region, 2025 Vs 2035 (%)
8. Global In-Vitro Fertilization (IVF) Equipment Market Share by Region, 2025 Vs 2035 (%)
9. Global In-Vitro Fertilization (IVF) Software Market Share by Region, 2025 Vs 2035 (%)
10. Global In-Vitro Fertilization (IVF) Market Share by End-User, 2025 Vs 2035 (%)
11. Global In-Vitro Fertilization (IVF) For Hospitals and Research Laboratories Market Share by Region, 2025 Vs 2035 (%)
12. Global In-Vitro Fertilization (IVF) For Fertility Clinics and Surgical Centers Market Share by Region, 2025 Vs 2035 (%)
13. Global In-Vitro Fertilization (IVF) For Other End User Market Share by Region, 2025 Vs 2035 (%)
14. Global In-Vitro Fertilization (IVF) Market Share By Region, 2025 Vs 2035 (%)
15. US In-Vitro Fertilization (IVF) Market Size, 2025–2035 ($ Million)
16. Canada In-Vitro Fertilization (IVF) Market Size, 2025–2035 ($ Million)
17. UK In-Vitro Fertilization (IVF) Market Size, 2025–2035 ($ Million)
18. France In-Vitro Fertilization (IVF) Market Size, 2025–2035 ($ Million)
19. Germany In-Vitro Fertilization (IVF) Market Size, 2025–2035 ($ Million)
20. Italy In-Vitro Fertilization (IVF) Market Size, 2025–2035 ($ Million)
21. Spain In-Vitro Fertilization (IVF) Market Size, 2025–2035 ($ Million)
22. Russia In-Vitro Fertilization (IVF) Market Size, 2025–2035 ($ Million)
23. Rest of Europe In-Vitro Fertilization (IVF) Market Size, 2025–2035 ($ Million)
24. India In-Vitro Fertilization (IVF) Market Size, 2025–2035 ($ Million)
25. China In-Vitro Fertilization (IVF) Market Size, 2025–2035 ($ Million)
26. Japan In-Vitro Fertilization (IVF) Market Size, 2025–2035 ($ Million)
27. South Korea In-Vitro Fertilization (IVF) Market Size, 2025–2035 ($ Million)
28. Australia and New Zealand In-Vitro Fertilization (IVF) Market Size, 2025–2035 ($ Million)
29. ASEAN Economies In-Vitro Fertilization (IVF) Market Size, 2025–2035 ($ Million)
30. Rest of Asia-Pacific In-Vitro Fertilization (IVF) Market Size, 2025–2035 ($ Million)
31. Latin America In-Vitro Fertilization (IVF) Market Size, 2025–2035 ($ Million)
32. Middle East and Africa In-Vitro Fertilization (IVF) Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of user within the company
Contact Sales
FAQS
The size of the In-Vitro Fertilization (IVF) Market in 2025 is estimated to be around $1,050.0 Million.
North America holds the largest share in the In-Vitro Fertilization (IVF) Market.
Leading players in the In-Vitro Fertilization (IVF) Market include CooperSurgical Inc., Cook Medical Inc., Merck KGaA, Thermo Fisher Scientific Inc., Vitrolife AB, among others.
The In-Vitro Fertilization (IVF) Market is expected to grow at a CAGR of 8.3% from 2026 to 2035.
The In-Vitro Fertilization (IVF) Market is driven by rising infertility rates and increasing demand for assisted reproductive technologies.
